17 results for “Treatment COVID-19”

Set a search alert

Review ArticleOpen accessIn the abstractDrug Repositioning in Response to COVID-19 and other Challenging DiseasesHyellavala Joseph Fomnya, Saidu Ibrahim Ngulde, Sarah Malgwi Gana et al.Coronavirus disease is a highly contagious infection that is majorly associated with upper respiratory tract illnesses. The World Health Organization (WHO) label the novel coronavirus disease COVID-19 after an epidemic of the disease in Wuhan, Hubei province (China). Over 90 clinical trials, including drug repositioning, have been initiated to get COVID-19 treatment/management. Antibiotic resistance, drug tolerance, mutation, and adverse drug … …American Journal of Pharmacology and Toxicology, Vol. 17, Issue 1 · 28 Nov 2022 · 9,508 accessesView PDF Cite

Review ArticleOpen accessIn the abstractArtificial Intelligence in e-Health: A Review of Current Status in Healthcare and Future Possible Scope of ResearchSapna Katiyar, Artika FarhanaArtificialIntelligence (AI) has been emerging promptly currently due to softwarealgorithms, hardware employment, and applications in many sectors. TheHealthcare sector is drawing the attention of healthcare professionals andresearchers from a multidisciplinary viewpoint like administration, business,finance, record keeping, decision making, and services. Extensive usage ofelectronic health records gives rise to an immense quantity of clinical data.For patient welfare, disease diagnosis is vital … …Journal of Computer Science, Vol. 18, Issue 10 · 6 Oct 2022 · 6,287 accessesView PDF Cite

Research ArticleOpen accessIn the abstractCharacteristics and Incidence of Candidemia in Hospitalized Coronavirus 2019 (COVID-19) PatientsNaana A Boachie, Jackie P. Johnston, Simi A. Philip et al.Management of Coronavirus 2019 (COVID-19) with high-dose corticosteroids and interleukin-2 inhibitors has potential benefits, but is associated with immunosuppression and risk of secondary infections. This single-center, retrospective, cohort study evaluated the incidence of candidemia and associated risk factors in hospitalized COVID-19 patients. Twenty-three patients developed candidemia and were matched to 77 non-candidemic COVID-19 controls. The primary outcome was incidence of … …American Journal of Infectious Diseases, Vol. 18, Issue 1 · 18 Jan 2022 · 7,604 accessesView PDF Cite

Research ArticleOpen accessIn the abstractImpact and Control of Drug Therapy Guidelines for Tumor Patients During the Novel Coronavirus Pneumonia EpidemicRazi Ahmed, Shafiza Mohd Shariff, Shahrinaz Ismail et al.Since December 2019, many unexplained viral pneumonia cases have been found in Wuhan City, Hubei Province, China. It was later confirmed that the outbreak's causative agent was a new coronavirus. The virus was temporarily named "2019-new coronavirus" (2019-nCoV) by the World Health Organization (WHO). The diseases caused by 2019-nCoV were called by the National Health and Health Commission of China … …Journal of Computer Science, Vol. 17, Issue 8 · 9 Sep 2021 · 6,688 accessesView PDF Cite

Research ArticleOpen accessIn the abstractAsymptomatic COVID-19 Patients: Experience and Lessons from a Developing CountrySylvie Kolani, Houda Alami, El Harch ibtissam et al.The world is facing a pandemic due to the SARS-Coronavirus 2, since late 2019. Many questions remain unanswered regarding the disease course. Key amongst its talking point is the case of asymptomatic patients. This potentially jeopardizes infection control strategy as asymptomatic cases are difficult to identify and hence difficult to isolate. Our study intends to define the clinical and radiological … …American Journal of Infectious Diseases, Vol. 17, Issue 2 · 22 May 2021 · 7,136 accessesView PDF Cite

Review ArticleOpen accessIn the abstractCOVID 19-How is the Exposure of the Pediatric Population? A Systematic Review ProtocolVitória Monteiro Monte Oliveira, Paulo Francisco de Almeida-Neto, Francisca Dalila Paiva Damasceno de Lima et al.Solid information on exposure and how to treat COVID-19 in pediatric patients is not yet conclusive in the literature, because of this it is necessary to make a critical analysis of the available data in order to provide common points on the theme in question. This systematic review protocol is registered in PROSPERO (ID: CRD42020181835) and aims through searches in … …American Journal of Infectious Diseases, Vol. 17, Issue 2 · 12 Apr 2021 · 6,869 accessesView PDF Cite

Research ArticleOpen accessAll words, across the recordProbabilistic Mechanics of Glass Suggests a Model for COVID-19 EpidemicsGabriele Pisano, Antonio Bonati, Gianni Royer CarfagniThe presented statistical model allows us to identify the degree of development of an epidemic starting from the observation of the number of deaths in the invested region, categorized by the age of the victims. Recognition of which cases are associated with the disease is not necessary, as this results from the comparison with data on deaths in pre-epidemic conditions. … …International Journal of Structural Glass and Advanced Materials Research, Vol. 6, Issue 1 · 26 Jan 2023 · 8,917 accessesView PDF Cite